Dr Reddys Laboratories RDY
NYSE RDY
$12.23 +0.12 (+0.99%)
At close: Aug 20, 2026 · 11:18 AM UTC

Dr Reddys Laboratories (RDY) Interest & Investment Income (2009 - 2019)

Dr Reddys Laboratories (RDY) posted quarterly Interest & Investment Income of -$6.0 million for Q3 2019, down 100.0% quarter-over-quarter from -$3.0 million in Q2 2019.

Dr Reddys Laboratories (RDY) Interest & Investment Income (2009 - 2019) Analysis & Trends

Dr Reddys Laboratories' Interest & Investment Income history runs 4 years deep, the most recent figure standing at -$6.0 million for Q3 2019.

  • In Q3 2019, Interest & Investment Income changed N/A year-over-year to -$6.0 million; the TTM figure through Sep 2019 stood at -$15.0 million (changed N/A YoY), while the FY2026 annual figure was $84.0 million, down 4.55% from the prior year.
  • Interest & Investment Income for Q3 2019 stood at -$6.0 million, down from -$3.0 million in the prior quarter.
  • The five-year high for Interest & Investment Income was -$3.0 million in Q2 2019, with the low at -$6.0 million in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Haleon 43.94 Bn 42.97 Bn - -
2 Teva Pharmaceutical Industries 43.21 Bn 39.55 Bn 2.15 Bn -
3 Zoetis 31.74 Bn 30.06 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.68 Bn 22.88 Bn 5.10 Bn 154.39 Mn
5 United Therapeutics 22.20 Bn 19.54 Bn 683.80 Mn 31.50 Mn
6 Viatris 18.80 Bn 17.91 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.70 Bn 15.31 Bn 935.80 Mn 12.40 Mn
8 Elanco Animal Health 12.14 Bn 11.61 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.17 Bn 10.01 Bn - -
10 Alkermes 8.23 Bn 7.57 Bn 397.90 Mn 5.34 Mn

Historic Data

Download Data
DateValue
Sep 30, 2019 -6.00 Mn
Jun 30, 2019 -3.00 Mn
Mar 31, 2019 -6.00 Mn
Mar 31, 2014 -1.00
Sep 30, 2010 10.00 Mn
Jun 30, 2010 -7.00 Mn
Mar 31, 2010 -2.00 Mn
Dec 31, 2009 1.00 Mn
Sep 30, 2009 -2.00 Mn
Jun 30, 2009 -6.00 Mn
Mar 31, 2009 -7.00 Mn